These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34525888)

  • 1. Nocturnal hypoglycemia in type 1 and type 2 diabetes: an update on prevalence, prevention, pathophysiology and patient awareness.
    Siamashvili M; Davis HA; Davis SN
    Expert Rev Endocrinol Metab; 2021 Nov; 16(6):281-293. PubMed ID: 34525888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile.
    Grassi B; Onetto MT; Zapata Y; Jofré P; Echeverría G
    Diabetes Metab Syndr; 2021; 15(3):695-701. PubMed ID: 33813244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort.
    Müller L; Habif S; Leas S; Aronoff-Spencer E
    Diabetes Technol Ther; 2019 Sep; 21(9):478-484. PubMed ID: 31329468
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.
    Maahs DM; Calhoun P; Buckingham BA; Chase HP; Hramiak I; Lum J; Cameron F; Bequette BW; Aye T; Paul T; Slover R; Wadwa RP; Wilson DM; Kollman C; Beck RW;
    Diabetes Care; 2014 Jul; 37(7):1885-91. PubMed ID: 24804697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
    Alotaibi A; Al Khalifah R; McAssey K
    Pediatr Diabetes; 2020 Nov; 21(7):1256-1267. PubMed ID: 32738022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
    Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
    Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
    Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
    Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensor-Augmented Insulin Pumps and Hypoglycemia Prevention in Type 1 Diabetes.
    Steineck I; Ranjan A; Nørgaard K; Schmidt S
    J Diabetes Sci Technol; 2017 Jan; 11(1):50-58. PubMed ID: 28264173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Glucose Monitoring: Impact on Hypoglycemia.
    van Beers CA; DeVries JH
    J Diabetes Sci Technol; 2016 Nov; 10(6):1251-1258. PubMed ID: 27257169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.
    Choudhary P; Rickels MR; Senior PA; Vantyghem MC; Maffi P; Kay TW; Keymeulen B; Inagaki N; Saudek F; Lehmann R; Hering BJ
    Diabetes Care; 2015 Jun; 38(6):1016-29. PubMed ID: 25998294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Predictive Low Glucose Suspend and Its Effectiveness in Preventing Nocturnal Hypoglycemia.
    Chen E; King F; Kohn MA; Spanakis EK; Breton M; Klonoff DC
    Diabetes Technol Ther; 2019 Oct; 21(10):602-609. PubMed ID: 31335193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions That Restore Awareness of Hypoglycemia in Adults With Type 1 Diabetes: A Systematic Review and Meta-analysis.
    Yeoh E; Choudhary P; Nwokolo M; Ayis S; Amiel SA
    Diabetes Care; 2015 Aug; 38(8):1592-609. PubMed ID: 26207053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel CGM Metric-Gradient and Combining Mean Sensor Glucose Enable to Improve the Prediction of Nocturnal Hypoglycemic Events in Patients with Diabetes.
    Li J; Ma X; Tobore I; Liu Y; Kandwal A; Wang L; Lu J; Lu W; Bao Y; Zhou J; Nie Z
    J Diabetes Res; 2020; 2020():8830774. PubMed ID: 33204733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology to Reduce Hypoglycemia.
    Yeoh E; Choudhary P
    J Diabetes Sci Technol; 2015 Jul; 9(4):911-6. PubMed ID: 25883167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes.
    Calhoun PM; Buckingham BA; Maahs DM; Hramiak I; Wilson DM; Aye T; Clinton P; Chase P; Messer L; Kollman C; Beck RW; Lum J;
    J Diabetes Sci Technol; 2016 Nov; 10(6):1216-1221. PubMed ID: 27207890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.